Top compounds associated with response to SLC11A2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.03
mRNA RITA CTRPv2 pan-cancer AAC 0.08 0.03
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.12 0.03
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.073 0.03
mRNA PD-0332991 GDSC1000 pan-cancer AAC 0.075 0.03
mRNA brivanib CTRPv2 pan-cancer AAC -0.079 0.03
mRNA Irinotecan CCLE pan-cancer AAC -0.12 0.03
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.083 0.03
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.03
mRNA Epothilone B GDSC1000 pan-cancer AAC 0.075 0.03
Download CSV